Amphastar Pharmaceuticals (AMPH) Other Non-Current Assets (2013 - 2026)

Amphastar Pharmaceuticals' Other Non-Current Assets history runs 14 years deep, the most recent figure standing at $33.5 million for Q1 2026.

• On a quarterly basis, Other Non-Current Assets rose 45.62% year-over-year to $33.5 million in Q1 2026; TTM through Mar 2026 was $33.5 million, a 45.62% increase from a year earlier, with the FY2025 full-year figure at $31.1 million, up 19.79% from the prior year.
• Other Non-Current Assets rose to $33.5 million in Q1 2026 per AMPH's latest filing, from $31.1 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $33.5 million in Q1 2026 and bottomed at $16.3 million in Q1 2022.
• The 5-year median for Other Non-Current Assets is $23.7 million (2024), against an average of $24.1 million.
• Across the five-year window, Other Non-Current Assets surged 126.03% in 2022 and fell 6.47% in 2024, its largest moves.
• Year by year, Other Non-Current Assets stood at $20.9 million in 2022, then climbed by 24.23% to $25.9 million in 2023, then gained by 0.32% to $26.0 million in 2024, then gained by 19.79% to $31.1 million in 2025, then increased by 7.53% to $33.5 million in 2026.
• Per Business Quant, the three latest AMPH Other Non-Current Assets figures stand at $33.5 million (Q1 2026), $31.1 million (Q4 2025), and $29.9 million (Q3 2025).